Vlachou M, Mauri D, Zarkavelis G, Ntellas P, Tagkas C, Gkoura S, et al. Plasma ctDNA RAS status selects patients for anti-EGFR treatment rechallenge in metastatic colorectal cancer: a meta-analysis. Exp. oncol. [Internet]. 2023 May 26 [cited 2026 Apr. 27];43(3):252-6. Available from: https://exp-oncology.com.ua/index.php/Exp/article/view/2021-3-17